Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Omeprazole (Proton Pump Inhibitor)
Treatment for Gastritis and duodenitis
Typical Dosage: 20-40mg once daily
Effectiveness
85%
Safety Score
75%
Clinical Trials
5,000
Participants
500K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
20-40mg once daily
Time to Effect
Days to 2 weeks for symptom relief, 4-8 weeks for healing
Treatment Duration
4-8 weeks, or longer for chronic conditions
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$50
Side Effect Mgmt:$20
Total Annual:$270
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$15,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$300
Cost per Remission
$338
Comparison vs Famotidine (H2 Blocker)
Cost Difference
+$60/year
More expensive
QALY Difference
+0.05 QALYs
Better outcomes
Dominance
No dominance
Omeprazole (Proton Pump Inhibitor) Outcomes
for Gastritis and duodenitis
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+90%
Remission Rate
+80%
Common Side Effects
Headache
+8%
Nausea
+5%
Diarrhea
+4%
Abdominal pain
+3%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov